Shares of industrial products company CSW (NYSE:CSW)
jumped 5.4% in the afternoon session after the broader market rebounded from a tech-driven sell-off, with investors taking the opportunity to buy stocks at lower prices.
Shares of payment solutions provider WEX (NYSE:WEX) jumped 7.3% in the afternoon session after the company reported strong fourth-quarter results that surpassed expectations and issued a positive forecast for 2026.
Shares of computer processor maker Intel (NASDAQ:INTC)
jumped 4.6% in the afternoon session after reports revealed that the company planned to raise server CPU prices amid shortages, coupled with a massive spending forecast from cloud giant Amazon.
The optimistic start to 2026 has been abruptly halted as the S&P 500 index officially turned red for the year during a volatile trading session on February 6, 2026. After a promising January that saw the index climb 1.4%, a brutal three-day rout has wiped out nearly $1
Shares of athletic apparel company Under Armour (NYSE:UAA)
jumped 13.2% in the morning session after the company reported fourth-quarter results that beat Wall Street's expectations and raised its full-year profit forecast.
Shares of plant-based food and beverage company SunOpta (NASDAQ:STKL)
jumped 31.8% in the morning session after the company agreed to be acquired by beverage solutions provider Refresco for $6.50 per share in cash.
Shares of global satellite communications provider Viasat (NASDAQ:VSAT) jumped 7.4% in the morning session after the company reported fourth-quarter results that showed a significant earnings beat, even as revenue came in slightly below forecasts.
Shares of investment banking firm Piper Sandler (NYSE:PIPR) jumped 8.5% in the morning session after the company reported strong fourth-quarter 2025 results that significantly surpassed Wall Street's expectations for both revenue and earnings.
Shares of blockchain infrastructure company Coinbase (NASDAQ:COIN) jumped 9.5% in the morning session after the price of Bitcoin rebounded from a significant drop, sparking a relief rally across crypto-related stocks.
Shares of packaged foods company Post (NYSE:POST)
jumped 9.5% in the morning session after the company reported strong fourth-quarter 2025 results that surpassed analyst expectations and raised its full-year financial outlook.
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 22.4% year on year to $13.25 million. Its non-GAAP loss of $0.29 per share was 13.9% above analysts’ consensus estimates.
Shares of creative software giant Adobe (NASDAQ:ADBE) fell 3.1% in the afternoon session after the "AI replacement" narrative reached a fever pitch following the release of new models from Anthropic and OpenAI.
Shares of cloud data platform provider Snowflake (NYSE:SNOW) fell 3.9% in the afternoon session after the "AI replacement" narrative reached a fever pitch following the release of new models from Anthropic and OpenAI.
Shares of battery manufacturer EnerSys (NYSE:ENS)
fell 12.7% in the afternoon session after the company reported fourth-quarter results that missed revenue expectations and showed a decline in sales volume, raising concerns about slowing demand.
Shares of healthcare distributor Cencora (NYSE:COR)
jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year guidance.
Shares of industrial construction and maintenance company Matrix Service (NASDAQ:MTRX)
fell 14.4% in the afternoon session after it reported disappointing fourth-quarter 2025 results that missed Wall Street's expectations.
Shares of network chips maker MACOM Technology Solutions (NASDAQ: MTSI)
jumped 7.4% in the afternoon session after the company reported strong fourth-quarter 2025 financial results that beat expectations and issued an optimistic outlook for the first quarter of 2026.
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY)
fell 7.4% in the morning session after the company discontinued three clinical pipeline assets, including a gene therapy for dementia acquired through a billion-dollar deal.
Shares of non-lethal weapons company Byrna (NASDAQ:BYRN)
jumped 15.1% in the pre-market session after the company reported calendar fourth-quarter 2025 results, with revenue that narrowly beat Wall Street's expectations. For the quarter, revenue grew 26% year-over-year to $35.25 million, just ahead of consensus estimates. The company's earnings per share of $0.14 was in line with projections. However, the report presented a mixed picture for investors. Adjusted EBITDA slightly missed analyst forecasts, and the company's operating margin contracted to 11.2% from 14.6% in the same period last year, suggesting a decrease in efficiency as expenses outpaced revenue growth.
Shares of exercise equipment company Peloton (NASDAQ:PTON)
fell 23.2% in the morning session after the company reported disappointing fourth-quarter results and provided a weak outlook for the upcoming quarter and full year.
As the first week of February 2026 unfolds, a dramatic shift in investor sentiment has split the U.S. stock market. While technology and artificial intelligence stocks have faced a sharp pullback, the healthcare sector has emerged as the market's primary engine of growth. The Dow Jones Industrial Average surged
